Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119963) titled 'Large-Scale Proteomic Profiling for Identification and Validation of Novel Plasma Biomarkers in Alzheimer's Disease' on March 6.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology
Condition:
Alzheimer's Disease
Intervention:
Healthy Volunteers (Control Group):None
Mild Cognitive Impairment (MCI Group):None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: Healthy Volunteers (Control Group):55;Mild Cognitive Impairment (MCI Group):...